Sign up for the latest updates on immunization-related science, policy, and access from the International Vaccine Access Center with our monthly newsletter, Vaccine Access Digest.
With flu season around the corner and expected upticks in cases of COVID-19 and respiratory syncytial virus (RSV), we can anticipate a perfect storm of respiratory viruses — often referred to as a “tripledemic”.
IVAC team members traveled to N’Djamena, Chad, earlier this month for a workshop focused on accelerating the introduction of pneumococcal conjugate vaccine (PCV) and rotavirus vaccine.
The three-day meeting included workshops to co-create strategies for vaccine demand generation, such as ideas for IEC materials for beneficiaries, trainings for healthcare providers, and policy briefs.
The recently released WHO and UNICEF national estimates of immunization coverage (WUENIC) shows that continued efforts are needed to ensure equitable access to vaccines.
A panel of distinguished experts discussed the ongoing threat of measles, why vaccination is critical to prevent this extremely contagious disease, and the impact of vaccine hesitancy on declining immunization rates.
TB is currently one of the world’s leading infectious killers, second only to COVID-19, though it has received just a fraction of the attention of the COVID-19 pandemic.
In recognition of International Women’s Day on March 8, IVAC is spotlighting several projects that support the critical relationship between immunization and gender equity for women and girls.
IVAC health economists recently published several papers focusing on the cost of procuring and delivering life-saving vaccines to increase coverage and meetImmunization Agenda 2030 (IA 2030) targets.
IVAC’sGlobal Advocacy for PCVproject put together an evidence-based brief compendium on PCV use globally and within the EMRO region upon request from key decision-makers in Jordan.
